StonvexLoading…
StonvexStonvexStonvexCore line items from QLYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $669.13M | $607.57M | $554.46M | $489.72M |
Operating Income | $221.95M | $187.20M | $163.07M | $130.55M |
Net Income | $198.32M | $173.68M | $151.59M | $107.99M |
EPS (Diluted) | $5.44 | $4.65 | $4.03 | $2.74 |
Total Assets | $1.10B | $973.54M | $812.62M | $700.94M |
Total Liabilities | $533.93M | $496.42M | $444.44M | $411.81M |
Cash & Equivalents | $250.26M | $232.18M | $203.66M | $173.72M |
Free Cash Flow OCF − CapEx | $304.41M | $231.76M | $235.82M | $183.49M |
Shares Outstanding | 35.73M | 36.50M | 36.91M | 37.36M |